STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 79 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q3 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $388,000 | +52.8% | 190,057 | +122.3% | 0.00% | – |
| Q2 2021 | $254,000 | +1.6% | 85,489 | -5.5% | 0.00% | – |
| Q1 2021 | $250,000 | +190.7% | 90,476 | +153.1% | 0.00% | – |
| Q4 2020 | $86,000 | +207.1% | 35,750 | +167.0% | 0.00% | – |
| Q3 2020 | $28,000 | -28.2% | 13,391 | +30.0% | 0.00% | – |
| Q2 2020 | $39,000 | +105.3% | 10,300 | +0.8% | 0.00% | – |
| Q1 2020 | $19,000 | -40.6% | 10,223 | -33.3% | 0.00% | – |
| Q4 2019 | $32,000 | -27.3% | 15,318 | -16.0% | 0.00% | – |
| Q3 2019 | $44,000 | -94.3% | 18,239 | -92.6% | 0.00% | – |
| Q2 2019 | $778,000 | +56.2% | 248,141 | +199.2% | 0.00% | – |
| Q2 2018 | $498,000 | – | 82,924 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,612,065 | $12,497,000 | 13.66% |
| Ikarian Capital, LLC | 3,392,787 | $6,412,000 | 0.48% |
| NEA Management Company, LLC | 4,141,308 | $7,827,000 | 0.41% |
| Alambic Investment Management, L.P. | 61,764 | $117,000 | 0.28% |
| KNOTT DAVID M | 181,800 | $344,000 | 0.22% |
| 683 Capital Management, LLC | 917,942 | $1,736,000 | 0.10% |
| Hudson Bay Capital Management LP | 1,409,419 | $2,664,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 388,309 | $734,000 | 0.06% |
| &PARTNERS | 15,000 | $28,000 | 0.04% |
| Diversified Trust Co | 198,534 | $375,000 | 0.02% |